期刊文献+

核糖核酸干扰下调骨桥蛋白表达对胃癌细胞生物学行为的影响 被引量:1

Down-regulation of osteopontin by siRNA on the biological behavior of gastric cancer cell lines
原文传递
导出
摘要 目的探讨骨桥蛋白(OPN)下调对胃癌细胞株MKN28和SGC7901生物学行为的影响。方法参考相关文献,设计并合成OPN的小干扰RNA(siRNA),通过荧光标记测定2株细胞的转染效率。Western印迹法检测OPN蛋白下调情况。实时定量聚合酶链反应(RT-PCR)检测siRNA对OPN mRNA的下调率及随时间的变化。流式细胞仪检测转染前、后细胞周期和凋亡变化。四甲基偶氮唑蓝(MTT)法连续7d检测OPN干扰时肿瘤细胞增殖的变化,并采用混合模型进行统计分析。Trans- well实验检测转染前、后细胞的运动侵袭能力并行t检验进行分析。结果2株细胞中OPN siRNA的转染效率均在90%以上。干扰后2株细胞中OPN蛋白表达均下调。SGC7901细胞在siRNA转染后72hOPN mRNA表达下降最低,达47%;MKN28细胞在siRNA转染后48hOPN mRNA表达下降最低,达40%。OPN被干扰后,SGC7901和MKN28细胞的增殖能力明显减弱(混合模型分析与未干扰组比较,P<0.01)。OPN被干扰后MKN28和SGC7901细胞周期受到影响,其中SGC7901分裂期细胞比例由18.78%降至17.02%,MKN28分裂期细胞比例则由4.96%降至0.39%。2株细胞都未发现下调OPN后诱发细胞凋亡。OPN下调后2株肿瘤细胞的运动侵袭能力均下降,穿过人工基底膜的细胞数明显减少(SGC7901:t=5.172,P<0.01;MKN28:t=11.365,P<0.01)。结论siRNA能下调MKN28和SGC7901中OPN表达,OPN可能与MKN28和SGC7901细胞的增殖和运动侵袭相关。 Objective To explore the effects of down regulation of osteopontin (OPN) on the biological behavior of MKN28 and 8GC7901 cell lines. Methods OPN siRNA was designed according to the relevant literature and was transfected into the two cell lines. Fluorescent labeling was used to test the transfected efficiency. The down-regulation of OPN protein was measured by Western blot. Realtime PCR was used to test the ratio and time difference of down-regulation of OPN mRNA after siRNA transfection. The biological changes before and after OPN siRNA transfected into these two cell lines were tested by flow cytometry (to test cell cycle and apoptosis) and MTT method (to test the proliferation for the consecutive seven days) and the difference between OPN siRNA transfected or non-transfected cells was compared using mixed model. The capability of moving and invasion of cancer cells were tested by Transwell method and analyzed by t-test. Results The transfected efficiency of OPN siRNA were more than 90% in the two cell lines. OPN mRNA down-regulated to 47% at the 72th hour in SGC7901, while 40% at the 48th hour in MKN28. The expression of OPN protein was both downregulated after siRNA transfection in the two cell lines. The proliferation decreased after transfected withOPN siRNA both in MKN28 and SGC7901( P 〈 0.01). The cell cycle was interfered by transfection with OPN siRNA, the proportion of M phase cells decreased from 4.96% to 0.39% in MKN28 and from 18.78% to 17.02% in SGC7901. No apoptosis was induced after transfection in the two cell lines.Transwell experiment showed less cells moving through the artificial basement membrane after transfected with OPN siRNA (SGC7901: t = 5. 172, P 〈. 0.01; MKN28: t = 11. 365, P 〈. 0.01). Conclusions The siRNA can down-regulated OPN, which may be a factor associated with proliferation, movement and invasion, in MKN28 and SGC7901 cell lines.
出处 《中华消化杂志》 CAS CSCD 北大核心 2007年第11期736-740,共5页 Chinese Journal of Digestion
关键词 骨桥蛋白 胃癌 核糖核酸 小干扰 Osteopontin Stomach neoplasms RNA, small interfering
  • 相关文献

参考文献14

  • 1朱晓群,叶青海,雷科峰,陈洁,钦伦秀.特异性小干扰性RNA降低骨桥蛋白基因表达对肝癌细胞侵袭性的影响[J].中华肿瘤杂志,2006,28(6):404-407. 被引量:12
  • 2Senger DR, Perruzzi CA, Papadopoulos A. Elevated expression of secreted phosphoprotein Ⅰ(osteopontin, 2at)as a consequence of neoplastic transformation. Anticancer Res, 1989, 9: 1291-1299.
  • 3Teramoto H, Castellone MD, Malek RL, et al. Autocrine activation of an osteopontin-CD44-Rac pathway enhances invasion and transformation by H-RasV12. Oncogene, 2005, 24: 489-501
  • 4Agrawal D, Chen T, Irby R, et al. Osteopontin identified as lead marker of colon cancer progression, using pooled sample expression profiling. J Natl Cancer Inst, 2002, 94:513-521.
  • 5Coppola D, Szabo M, Boulware D, et al. Correlation of osteopontin protein expression and pathological stage across a wide variety of tumor histologies. Clin Cancer Res, 2004, 10:184-190.
  • 6Ue T, Yokozaki H, Kitadai Y, et al. Co expression of osteopontin and CD44v9 in gastric cancer.Int J Cancer, 1998, 79:127-129.
  • 7Brakora KA, Lee H, Yusuf R, et al. Utility of osteopontin as a biomarker in recurrent epithelial ovarian cancer. Gynecol Oncol, 2004,93 : 361-365.
  • 8Carlinfante G, Vassiliou D, Svensson O, et al. Differential expression of osteopontin and bone sialoprotein in bone metastasis of breast and prostate carcinoma. Clin Exp Metastasis, 2003,20:437-444.
  • 9Tuck AB, Chambers AF. The role of osteopontin in breast cancer : clinical and experimental studies. J Mammary Gland Biol Neoplasia, 2001, 6:419-429.
  • 10Moye VE, Barraclough R, West C, et al. Osteopontin expression correlates with adhesive and metastatic potential in metastasis-inducing DNA-transfected rat mammary cell lines. Br J Cancer, 2004, 90:1796-1802.

二级参考文献1

共引文献11

同被引文献12

  • 1朱晓群,叶青海,雷科峰,陈洁,钦伦秀.特异性小干扰性RNA降低骨桥蛋白基因表达对肝癌细胞侵袭性的影响[J].中华肿瘤杂志,2006,28(6):404-407. 被引量:12
  • 2Muramatsu T, Shima K, Ohta K,et al. Inhibition of osteopontin expression and function in oral cancer cell lines by antisense oligonucleotides[J]. Cancer Lett,2005, 217( 1 ) :87 -95.
  • 3Tuck AB, Hota C, Wilson SM, et al. Osteopontin-induced migration of human mammary epithelial cells involves activation of EGF receptor and multiple signal transduction pathways[ J ]. Oncogene,2003, 22(8) : 1198 - 1205.
  • 4Zohar R, Suzuki N, Suzuki K, et al. Intracellular osteopontin is an integral component of the CD44-ERM complex involved in cell migration[J]. J Cell Physiol, 2000, 184(1): 118-130.
  • 5Wai PY, Kuo PC. The role of osteopontin in tumor metastasis [J]. J Surg Res, 2004, 121(2) : 228 -241.
  • 6Hammond SM, Bernstein E, Beach D, et al. An RNA directed nuclease mediates post-transcriptional gene silencing in drosophila cells [ J ]. Nature,2000,404 (6775) :293 - 296.
  • 7Das R, Mahabeleshwar GH, Kundu GC. Osteopontin stimulates cell motility and nuclear factor kappaB-mediated secretion of uro- kinase type plasminogen activator through phosphatidylinositol 3- kinase/Akt signaling pathways in breast cancer cells [ J ]. J Biol Chem, 2003,278 ( 31 ) : 28593 - 28606.
  • 8Das R, Mahabeleshwar GH, Kundu GC. Osteopontin induces AP-1-mediated secretion of urokinase-type plasminogen activator through c-Src-dependent epidermal growth factor receptor transactivation in breast cancer cells [ J ]. J Biol Chem, 2004, 279 (12) : 11051 -11064.
  • 9Rangaswami H, Bulbule A, Kundu GC. Nuclear factor-inducing kinase plays a crucial role in osteopontin-induced MAPK/Ikappa- Balpha kinase-dependent nuclear factor kappaB-mediated promatrix metalloproteinase-9 activation[ J ]. J Biol Chem, 2004, 279 (37) :38921 -38935.
  • 10Lin YH, Yang-Yen HF. The osteopontin-CD44 survival signal involves activation of the phosphatidylinositol 3-kinase/Akt signaling pathway[J]. J Biol Chem, 2001, 276 (49): 46024 - 46030.

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部